Notices. Notice
388 words·~2 min read·
/register/2020/09/15/2020-20332A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4164-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket Nos. FDA-2013-N-0618, FDA-2010-N-0601, FDA-2010-N-0598, FDA-2013-N-1155, FDA-2010-N-0118, FDA-2020-N-0145, FDA-2010-N-0597, FDA-2014-N-0086, FDA-2016-N-2836, FDA-2019-N-5841, and FDA-2019-N-5973] Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals AGENCY: Food and Drug Administration, Health and Human Services (HHS). ACTION: Notice. SUMMARY: The Food and Drug Administration
(FDA)is publishing a list of information collections that have been approved by the Office of Management and Budget
(OMB)under the Paperwork Reduction Act of 1995. FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-7726, *PRAStaff@fda.hhs.gov* . SUPPLEMENTARY INFORMATION: The following is a list of FDA information collections recently approved by OMB under section 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control number and expiration date of OMB approval for each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the internet at *http://www.reginfo.gov/public/do/PRAMain* . An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. Table 1—List of Information Collections Approved by OMB Title of collection OMB control No. Date approval expires Reporting and Recordkeeping for Electronic Products—General Requirements 0910-0025 8/31/2023 Current Good Manufacturing Practice Regulations for Medicated Feed 0910-0152 8/31/2023 Good Manufacturing Practice Regulations for Type A Medicated Articles, 21 CFR Part 226 0910-0154 8/31/2023 Food Labeling Regulations 0910-0381 8/31/2023 Prior Notice of Imported Food Under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002 0910-0520 8/31/2020 Animal Drug User Fee Program 0910-0540 8/31/2023 Index of Legally Marketed Unapproved New Animal Drugs for Minor Species 0910-0620 8/31/2023 Potential Tobacco Product Violations Reporting Form 0910-0716 8/31/2023 Donor Risk Assessment Questionnaire for the FDA/National Heart, Lung, and Blood Institute—Sponsored Transfusion-Transmissible Infections Monitoring System—Risk Factor Elicitation 0910-0841 8/31/2023 Generic Clearance for Qualitative Data to Support Social and Behavioral Research for Food, Dietary Supplements, Cosmetics, and Animal Food and Feed 0910-0891 8/31/2023 Health Care Providers Understanding of Opioid Analgesic Abuse-Deterrent Formulations: Phase 2 and 3 Surveys 0910-0892 8/31/2023 Dated: September 9, 2020. Lowell J. Schiller, Principal Associate Commissioner for Policy. [FR Doc. 2020-20332 Filed 9-14-20; 8:45 am]
Connectionstraces to 1
Traces to 1 document
1 reference not yet in our index
- 21 CFR 226
Citation graph
cites case law
Cites 2Cited by 0 across 0 sources